Nutritional & Integrative Strategies in Cardiovascular Medicine
Next Step Clinical Course
Know anyone with heart disease or Lyme? You need this exciting book! Despite aggressive pharmaceutical and surgical interventions, coronary artery disease (CAD) is still the number #1 killer. Learn evidence-based nutrition and integrative therapies by leading experts in cardiovascular medicine. Topics include: nutrigenomics, omega-3s and other fats, gender-specific medicine, nutraceuticals, drug-nutrient interactions, toxins that affect Lyme carditis, and statin drug side effects.
Level 2 & 3 CPE
Suggested Performance Indicators: 4.1.2, 6.2.5, 8.1.5, 8.3.6, 10.2.4
CPE Type: 720 for Printed/Paper Tests, 740 for Web-based/Online Tests
Upon successful completion, the users will be able to:
1. Identify four metabolic promoters of heart disease.
2. Explain how the “French Paradox” was invented to explain the connection between saturated fat and the incidence of heart disease.
3. Describe three mechanisms through which cholesterol is normally regulated.
4. Compare three benefits of the statin drugs with three negative effects.
5. Be adept at using a Personal Risk Factor calculator to assess coronary heart disease or stroke risk.
6. Explain physiologically the link between hypertension, atherosclerosis, c-reactive protein, and serum lipid levels.
7. Identify ten ways nutrients and nutrition can positively affect dyslipidemia, hypertension, and metabolic syndrome.
8. Give three ways Naturopathic Medicine differs from traditional medicine in the treatment of cardiovascular disease.
9. Name three roles that dentistry plays in the cardiovascular and well-being of a person.
10. Describe how three man-made toxins affect Lyme carditis.
11. Give three special considerations for women and heart disease.
Why we chose this book
This book was edited and written by 16 experts in the integrative cardiovascular field. It contains the newest evidence-based research on the development or delay of CV disease. We now know that our lifestyle choices can reverse or delay the disease processes, making them more manageable with more years of improved quality of life.
About the author
Dr. Stephen Sinatra is a board-certified cardiologist with over 40 years of experience treating CV disease. He is an assistant clinical professor of medicine at the University of Connecticut School of Medicine in Farmington, CT.
Dr. Mark Houston is an associate clinical professor of medicine at Vanderbilt University School of Medicine, director of the Hypertension Institute and Vascular biology, and medical director of the Division of Human Nutrition at St Thomas Medical group in Nashville.